Fexapotide, also known as NX-1207, is used in the treatment of Benign Prostatic Hyperplasia. NX-1207 has selective pro-apoptotic properties, which induces focal cell loss in prostate leading to prostate volume reduction with both short- and long-term symptomatic improvement.
MedKoo Cat#: 414524
Name: Fexapotide
CAS#: 492447-54-8 (free base)
Chemical Formula: C90H163N27O25S
Exact Mass: 2054.2034
Molecular Weight: 2055.52
Elemental Analysis: C, 52.59; H, 7.99; N, 18.40; O, 19.46; S, 1.56
The following data is based on the product molecular weight 2,055.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
